Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Darwin Molecular and Geron investigate gene for premature aging

Sep. 26, 1997

Bristol-Myers Squibb and Genome Therapeutics sign database license agreement

Sep. 24, 1997

Geron, Johns Hopkins collaborate on stem cell research

Sep. 23, 1997

Genetronics receives Phase I SBIR grant for heparin delivery

Sep. 23, 1997

CIMA licenses OraSolv to Zeneca

Sep. 16, 1997

MIT licenses drug discovery technology to Dyax

Sep. 15, 1997

Vertex, Kissei to collaborate on MAP kinase inhibitors

Sep. 12, 1997

Drug discovery technology pioneered at Oncogene Science now patented

Sep. 12, 1997

Preliminary results reported for RMP-7/carboplatin

Sep. 9, 1997

Roche subscribes to Easy Access for Affymetrix GeneChip

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...